Use access key #2 to skip to page content.
$3.50 -1.10 (-23.91%)
10/10/2008 4:00 PM

PharmaNet Development Group, Inc. (PDGI)

CAPS Rating:
***

A drug development services company, providing a range of both early and late stage clinical drug development services to branded pharmaceutical, biotechnology, generic drug and medical device companies around the world.

View All Commentary (PDGI)

Recs

2

Avatar DWilsonDVM (82.56) Submitted: 9/21/06 5:37 AM : Outperform Start Price: $18.62 PDGI Score: -47.94

Formerly SFBC Int'l (SFCC), This company was blasted by bad press last year. Most, but not all is false. All the guilty players have since left the company and it has lost much of it's highly profitable stage I clinical trials. Margins have decreased, but should now have stabilized. Revenues continue to grow rapidly, despite loss of the study center in Miami.

Report this Post Replies: 0 | Reply

Featured Broker Partners